News Classification
Check category
News Center
In 2023
12-22
12-19
Viwit Pharmaceuticals' Lidocaine Injection Receives Official Approval by China NMPA
12-07
Viwit Pharmaceuticals' Vildagliptin API Receives Official Approval by China NMPA
10-31
Viwit Pharmaceuticals' Aprepitant API Receives Official Approval by China NMPA
10-30
Viwit Pharmaceuticals obtained the Drug Production License C
10-18
Viwit Pharmaceuticals’BFS Technology
09-18
Meeting Viwit Pharmaceuticals at CPHI Barcelona
Previous page
1
2
Next page
VIWIT 沪ICP备12014533号-2 Terms of Use